These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20005954)
1. Induced secretion of beta-hexosaminidase by human brain endothelial cells: a novel approach in Sandhoff disease? Batista L; Miller F; Clave C; Arfi A; Douillard-Guilloux G; Couraud PO; Caillaud C Neurobiol Dis; 2010 Mar; 37(3):656-60. PubMed ID: 20005954 [TBL] [Abstract][Full Text] [Related]
2. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731 [TBL] [Abstract][Full Text] [Related]
3. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta. Arfi A; Zisling R; Richard E; Batista L; Poenaru L; Futerman AH; Caillaud C J Neurochem; 2006 Mar; 96(6):1572-9. PubMed ID: 16441513 [TBL] [Abstract][Full Text] [Related]
4. Metabolic correction in microglia derived from Sandhoff disease model mice. Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933 [TBL] [Abstract][Full Text] [Related]
5. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974 [TBL] [Abstract][Full Text] [Related]
6. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration. Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246 [TBL] [Abstract][Full Text] [Related]
7. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167 [TBL] [Abstract][Full Text] [Related]
8. A novel missense mutation (C522Y) is present in the beta-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease. Kuroki Y; Itoh K; Nadaoka Y; Tanaka T; Sakuraba H Biochem Biophys Res Commun; 1995 Jul; 212(2):564-71. PubMed ID: 7626071 [TBL] [Abstract][Full Text] [Related]
9. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605 [TBL] [Abstract][Full Text] [Related]
10. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer. Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224 [TBL] [Abstract][Full Text] [Related]
11. Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. Neote K; McInnes B; Mahuran DJ; Gravel RA J Clin Invest; 1990 Nov; 86(5):1524-31. PubMed ID: 2147027 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574 [TBL] [Abstract][Full Text] [Related]
13. The biochemical basis of gangliosidoses. Sandhoff K; Conzelmann E Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704 [No Abstract] [Full Text] [Related]
14. Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant. Teixeira CA; Sena-Esteves M; Lopes L; Sá Miranda MC; Ribeiro MG Hum Gene Ther; 2001 Sep; 12(14):1771-83. PubMed ID: 11560770 [TBL] [Abstract][Full Text] [Related]
15. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. Yamaguchi A; Katsuyama K; Suzuki K; Kosaka K; Aoki I; Yamanaka S J Mol Med (Berl); 2003 Mar; 81(3):185-93. PubMed ID: 12682727 [TBL] [Abstract][Full Text] [Related]
16. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase. Tse R; Vavougios G; Hou Y; Mahuran DJ Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542 [TBL] [Abstract][Full Text] [Related]
17. Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice. Denny CA; Heinecke KA; Kim YP; Baek RC; Loh KS; Butters TD; Bronson RT; Platt FM; Seyfried TN J Neurochem; 2010 Jun; 113(6):1525-35. PubMed ID: 20374428 [TBL] [Abstract][Full Text] [Related]
18. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses. Harzer K Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344 [No Abstract] [Full Text] [Related]
19. In situ assessment of beta-hexosaminidase activity. Lacorazza HD; Jendoubi M Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557 [TBL] [Abstract][Full Text] [Related]
20. Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects GM2 Gangliosidosis in Sandhoff Mice. Osmon KJ; Woodley E; Thompson P; Ong K; Karumuthil-Melethil S; Keimel JG; Mark BL; Mahuran D; Gray SJ; Walia JS Hum Gene Ther; 2016 Jul; 27(7):497-508. PubMed ID: 27199088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]